Report

src

Global Psoriatic Arthritis Treatment Market By Product Type (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)) And By End-Users/Application (Oral, Parenteral) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2022 - 2028

 Report Code
 Category
 Published Date
 Pages
 Format
PM-11570
Healthcare
14 March 2022
150
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

Global Psoriatic Arthritis Treatment Market is accounted for xx USD million in 2022 and is expected to reach xx USD million by 2028 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Psoriatic Arthritis Treatment market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2028.

Psoriatic Arthritis Treatment Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2022 to 2028; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global Psoriatic Arthritis Treatment that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

By geography, this market has been segregated into five regions with revenue and growth rate of Psoriatic Arthritis Treatment from 2020 to 2028,

 • North America  (U.S., Canada, Mexico)
 • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
 • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
 • Latin America (Brazil, Rest of L.A.)
 • Middle East And Africa(Turkey, GCC, Rest of Middle East)

The major players operating into Psoriatic Arthritis Treatment Market include: 
  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Novartis AG (Basel, Switzerland)
  • Amgen (Califormia, United States)
  • Pfizer Inc. (New York, United States)
  • Johnson & Johnson Services, Inc. (New Jersey, United States)
  • Eli Lilly and Company (Indiana, United States)
  • AstraZeneca (Cambridge, United Kingdom)
  • Sanofi (Paris, France)
  • Bristol-Myers Squibb Company (New York, United States)
  • GlaxoSmithKline plc. (Brentford, United Kingdom)
  • Bayer AG (Leverkusen, Germany)

This report segments the Global Psoriatic Arthritis Treatment Market as follows:

Global Psoriatic Arthritis Treatment Market: Type Segment Analysis 
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  • Others

Global Psoriatic Arthritis Treatment Market: Application Segment Analysis 
  • Oral
  • Parenteral
  • Topical

There are 13 chapters to put on view for Psoriatic Arthritis Treatment Market:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview
Chapter 2: Market competition by Manufacturers
Chapter 3: Production by Regions
Chapter 4: Consumption by Regions
Chapter 5: Production, By Types, Revenue and Market share by Types
Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications
Chapter 7: Complete profiling and analysis of Manufacturers 
Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses
Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10: Marketing Strategy Analysis, Distributors/Traders
Chapter 11: Market Effect Factors Analysis
Chapter 12: Market Forecast
Chapter 13: Psoriatic Arthritis Treatment Research Findings and Conclusion, Appendix, methodology and data source

Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.

Industry Chain Analysis

Raw Material and Suppliers
Equipment and Suppliers
Manufacturing Process
Manufacturing Cost Structure
Manufacturing Plants Distribution Analysis

Available Customizations

We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.  

1.    Preface
        1.1.    Report Scope and Description
        1.2.    Research Methodology
                1.2.1.    Phase I-Secondary Research
                1.2.2.    Phase II-Primary Research
                1.2.3.    Phase II-Expert Panel Review
                1.2.4.    Assumptions
                1.2.5.    Approach Adopted
2.    Executive Summary
        2.1.    Global Psoriatic Arthritis Treatment Market Snapshot
                2.1.1.    Global Psoriatic Arthritis Treatment Market, By Type, 2021
                2.1.2.    Global Psoriatic Arthritis Treatment Market, By Application, 2021
                2.1.3.    Global Psoriatic Arthritis Treatment Market, By End-use, 2021
                2.1.4.    Global Psoriatic Arthritis Treatment Market, By Geography, 2021
3.    Global Psoriatic Arthritis Treatment Market Dynamics
        3.1.    Market Overview
        3.2.    Market Inclination Insights Analysis
        3.3.    Drivers
        3.4.    Challenges
        3.5.    Future Prospects
        3.6.    Impact Analysis of Drivers and Challenges During the Forecast Period, (2018-2028)
4.    Global Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        4.1.    Overview
                4.1.1.    Market Share Analysis By Type, 2021 vs 2028
                4.1.2.    Attractive Investment Proposition By Type, 2021
        4.2.    Global Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
                4.2.1.     Non-steroidal Anti-inflammatory Drugs (NSAIDS)
                4.2.2.     Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
                4.2.3.     Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)
                4.2.4.     Others
5.    Global Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        5.1.    Overview
                5.1.1.    Market Share Analysis By Application, 2021 vs 2028
                5.1.2.    Attractive Investment Proposition By Application, 2021
        5.2.    Global Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
                5.2.1.     Oral
                5.2.2.     Parenteral
                5.2.3.     Topical
6.    Global Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        6.1.    Overview
                6.1.1.    Market Share Analysis By End-use, 2021 vs 2028
                6.1.2.     Attractive Investment Proposition By End-use, 2021
        6.2.    Global Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
                6.2.1.    End-use1
                6.2.2.    End-use2
                6.2.3.    End-use3
                6.2.4.    End-use4
                6.2.5.    End-use5
                6.2.6.    End-use6
7.    North America Psoriatic Arthritis Treatment Market Analysis, 2018 – 2028
        7.1.    North America Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        7.2.    North America Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        7.3.    North America Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        7.4.    North America Psoriatic Arthritis Treatment Market Size (US$), By Country, 2018 – 2028
                7.4.1.    U.S.
                7.4.2.    Canada
8.    Europe Psoriatic Arthritis Treatment Market Analysis, 2018 – 2028
        8.1.    Europe Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        8.2.    Europe Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        8.3.    Europe Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        8.4.    Europe Psoriatic Arthritis Treatment Market Size (US$), By Country, 2018 – 2028
                8.4.1.    U.K.
                8.4.2.    Germany
                8.4.3.    France
                8.4.4.    Rest of Europe
9.    Asia Pacific Psoriatic Arthritis Treatment Market Analysis, 2018 – 2028
        9.1.    Asia Pacific Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        9.2.    Asia Pacific Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        9.3.    Asia Pacific Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        9.4.    Asia Pacific Psoriatic Arthritis Treatment Market Size (US$), By Country, 2018 – 2028
                9.4.1.    China
                9.4.2.    Japan
                9.4.3.    India
                9.4.4.    Rest of Asia Pacific
10.    Latin America Psoriatic Arthritis Treatment Market Analysis, 2018 – 2028
        10.1.    Latin America Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        10.2.    Latin America Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        10.3.    Latin America Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        10.4.    Latin America Psoriatic Arthritis Treatment Market Size (US$), By Country, 2018 – 2028
                10.4.1.     Brazil
                10.4.2.     Mexico
                10.4.3.     Rest of Latin America
11.    Middle East & Africa (MEA) Psoriatic Arthritis Treatment Market Analysis, 2018 – 2028
        11.1.    MEA Psoriatic Arthritis Treatment Market Size (US$), By Type, 2018 – 2028
        11.2.    MEA Psoriatic Arthritis Treatment Market Size (US$), By Application, 2018 – 2028
        11.3.    MEA Psoriatic Arthritis Treatment Market Size (US$), By End-use, 2018 – 2028
        11.4.    MEA Psoriatic Arthritis Treatment Market Size (US$), By Region, 2018 – 2028
                11.4.1.     GCC Countries
                11.4.2.    South Africa
                11.4.3.     Rest of MEA
12.    Company Profiles
        12.1.    Competitive Analysis
        12.2.    Market Positioning of Key Vendors
        12.3.    Key Strategies adopted by the Leading Players
        12.4.    F. Hoffmann-La Roche Ltd (Basel, Switzerland)
                12.4.1.    Business Description
                12.4.2.    Geographic Operations
                12.4.3.    Financial Information
                12.4.4.    Product Positions/Portfolio
                12.4.5.    Key Developments
        12.5.    Novartis AG (Basel, Switzerland)
                12.5.1.    Business Description
                12.5.2.    Geographic Operations
                12.5.3.    Financial Information
                12.5.4.    Product Positions/Portfolio
                12.5.5.    Key Developments
        12.6.    Amgen (Califormia, United States)
                12.6.1.    Business Description
                12.6.2.    Geographic Operations
                12.6.3.    Financial Information
                12.6.4.    Product Positions/Portfolio
                12.6.5.    Key Developments
        12.7.    Pfizer Inc. (New York, United States)
                12.7.1.    Business Description
                12.7.2.    Geographic Operations
                12.7.3.    Financial Information
                12.7.4.    Product Positions/Portfolio
                12.7.5.    Key Developments
        12.8.    Johnson & Johnson Services, Inc. (New Jersey, United States)
                12.8.1.    Business Description
                12.8.2.    Geographic Operations
                12.8.3.    Financial Information
                12.8.4.    Product Positions/Portfolio
                12.8.5.    Key Developments
        12.9.    Eli Lilly and Company (Indiana, United States)
                12.9.1.    Business Description
                12.9.2.    Geographic Operations
                12.9.3.    Financial Information
                12.9.4.    Product Positions/Portfolio
                12.9.5.    Key Developments
        12.10.    AstraZeneca (Cambridge, United Kingdom)
                12.10.1.    Business Description
                12.10.2.    Geographic Operations
                12.10.3.    Financial Information
                12.10.4.    Product Positions/Portfolio
                12.10.5.    Key Developments
        12.11.    Sanofi (Paris, France)
                12.11.1.    Business Description
                12.11.2.    Geographic Operations
                12.11.3.    Financial Information
                12.11.4.    Product Positions/Portfolio
                12.11.5.    Key Developments
        12.12.    Bristol-Myers Squibb Company (New York, United States)
                12.12.1.    Business Description
                12.12.2.    Geographic Operations
                12.12.3.    Financial Information
                12.12.4.    Product Positions/Portfolio
                12.12.5.    Key Developments
        12.13.    GlaxoSmithKline plc. (Brentford, United Kingdom)
                12.13.1.    Business Description
                12.13.2.    Geographic Operations
                12.13.3.    Financial Information
                12.13.4.    Product Positions/Portfolio
                12.13.5.    Key Developments
        12.14.    Bayer AG (Leverkusen, Germany)
                12.14.1.    Business Description
                12.14.2.    Geographic Operations
                12.14.3.    Financial Information
                12.14.4.    Product Positions/Portfolio
                12.14.5.    Key Developments

        

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase